Zynex Reports Fourth Quarter and Full Year 2023 Financial Results

FY 2023 Revenue Increased 17% to $184.3 Million Company Announces Additional $20 Million Stock Repurchase Plan ENGLEWOOD, Colo., Feb. 29, 2024 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks